Careteq (ASX:CTQ) Total Stockholders Equity: A$1.24 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Careteq Total Stockholders Equity?

Careteq ASX:CTQ Total Stockholders Equity is A$1.24 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Careteq's Total Stockholders Equity for the quarter that ended in Dec. 2025 was A$1.24 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Careteq's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Careteq's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.00.

Careteq  (ASX:CTQ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Careteq's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.243-0)/237.119
=0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Careteq's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 1.243
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careteq Total Stockholders Equity Related Terms

Careteq Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Careteq's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careteq Total Stockholders Equity Chart

Careteq Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Total Stockholders Equity
9.62 6.30 2.14 1.97 1.52

Careteq Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 3.63 1.97 0.94 1.52 1.24
What does a Total Stockholders Equity of A$1.24 Mil mean?
Careteq (ASX:CTQ) has a Total Stockholders Equity of A$1.24 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Careteq and its competitors.
Is Careteq's Total Stockholders Equity too high?
Careteq's current Total Stockholders Equity is A$1.24 Mil.
How does Careteq's Total Stockholders Equity compare to VEEV and BTSG?
Careteq's Total Stockholders Equity of A$1.24 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Careteq and its competitors. Careteq's current Total Stockholders Equity is A$1.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careteq stock overvalued right now?
Based on GuruFocus' analysis, Careteq (ASX:CTQ) is currently considered Fairly Valued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 10% above its estimated fair value. The current Total Stockholders Equity is A$1.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Careteq (ASX:CTQ), the current Total Stockholders Equity is A$1.24 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Careteq Business Description

Address 99 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuses on medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.